Clinicopathological Characteristics and Prognosis of Upper Gastric Cancer Patients in China: A 32-Year Single-Center Retrospective Clinical Study

被引:11
作者
Gong, Yingbo [1 ,2 ]
Wang, Pengliang [1 ,2 ]
Zhu, Zhi [1 ,2 ]
Zhang, Junyan [1 ,2 ]
Huang, Jinyu [1 ,2 ]
Xu, Huimian [1 ,2 ]
机构
[1] China Med Univ, Hosp 1, Dept Surg Oncol, 155 Nanjing North St, Shenyang 110001, Liaoning, Peoples R China
[2] Key Lab Gastr Canc Mol Pathol Liaoning Prov, 155 Nanjing North St, Shenyang 110001, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
PHASE-II; CURATIVE RESECTION; TOTAL GASTRECTOMY; TUMOR RECURRENCE; ADENOCARCINOMA; DEATH; CHEMOTHERAPY; DISSECTION; MORBIDITY; FEATURES;
D O I
10.1155/2019/9248394
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose. Upper or proximal gastric cancer occurs in the upper third of the stomach between the cardia and a line connecting the greater and lesser curvatures. As it differs from other gastric cancers in pathology and prognosis, we evaluated patient and disease characteristics that might guide improved treatment and survival of upper gastric cancer. Methods. We conducted a retrospective analysis of 649 patients with upper gastric cancer and 1551 patients with lower gastric cancer and R0 radical surgery at our institution between January 1980 and December 2012. Results. Survival after radical surgery for upper gastric cancer was 77.8% at 1 year, 49.6% at 3 years, and 41.1% at 5 years. The corresponding rates for lower gastric cancer were 85.9%, 60.0%, and 57.2% (p<0.001). Upper gastric cancer had a poor prognosis. Sex (p=0.036), tumor diameter (p=0.001), macroscopic type (p<0.001), pTM stage (p<0.001), tissue differentiation type (p=0.003), and serosal invasion (p=0.034) were independently associated with lymph node metastasis. The macroscopic type (p=0.045), lymphovascular tumor emboli (p=0.021), and pTNM stage were independently associated with recurrence and metastasis. Survival of 333 patients with D2 total gastrectomy was 81.3% at 1 year, 54.4% at 3 years, and 45.2% at 5 years. The corresponding rates for 316 proximal gastrectomy patients were 75.4%, 44.9%, and 36.7%. Radical total gastrectomy had better survival than radical proximal resection. Conclusions. Upper gastric cancers were more aggressive, had a worse prognosis, and were more prone to recurrence and metastasis compared with lower gastric cancers. Survival was better after total gastrectomy than after proximal resection.
引用
收藏
页数:12
相关论文
共 34 条
[1]  
Ajani JA, 1998, CANCER J SCI AM, V4, P269
[2]   Clinicopathological Features and Prognosis of Gastric Cardia Adenocarcinoma: A Multi-Institutional US Study [J].
Amini, Neda ;
Spolverato, Gaya ;
Kim, Yuhree ;
Squires, Malcolm H. ;
Poultsides, George A. ;
Fields, Ryan ;
Schmidt, Carl ;
Weber, Sharon M. ;
Votanopoulos, Konstantinos ;
Maithel, Shishir K. ;
Pawlik, Timothy M. .
JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (03) :285-292
[3]   The difficult choice between total and proximal gastrectomy in proximal early gastric cancer [J].
An, Ji Yeong ;
Youn, Ho Geun ;
Choi, Min Gew ;
Noh, Jae Hyung ;
Sohn, Tae Sung ;
Kim, Sung .
AMERICAN JOURNAL OF SURGERY, 2008, 196 (04) :587-591
[4]   RANDOMIZED COMPARISON OF MORBIDITY AFTER D1 AND D2 DISSECTION FOR GASTRIC-CANCER IN 996 DUTCH PATIENTS [J].
BONENKAMP, JJ ;
SONGUN, I ;
HERMANS, J ;
SASAKO, M ;
WELVAART, K ;
PLUKKER, JTM ;
VANELK, P ;
OBERTOP, H ;
GOUMA, DJ ;
TAAT, CW ;
VANLANSCHOT, J ;
MEYER, S ;
DEGRAAF, PW ;
VONMEYENFELDT, MF ;
TILANUS, H ;
VANDEVELDE, CJH .
LANCET, 1995, 345 (8952) :745-748
[5]   Postoperative morbidity and mortality after D-1 and D-2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial [J].
Cuschieri, A ;
Fayers, P ;
Fielding, J ;
Craven, J ;
Bancewicz, J ;
Joypaul, V ;
Cook, P .
LANCET, 1996, 347 (9007) :995-999
[6]   Cancer of the Gastric Cardia is Rising in Incidence in an Asian Population and is Associated with Adverse Outcome [J].
Deans, Chris ;
Yeo, Matthew S. W. ;
Soe, Mu Yar ;
Shabbir, Asim ;
Ti, T. K. ;
So, Jimmy B. Y. .
WORLD JOURNAL OF SURGERY, 2011, 35 (03) :617-624
[7]   Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: The eastern cooperative oncology group (ECOG) results of protocol E1293 [J].
Einzig, AI ;
Neuberg, D ;
Remick, SC ;
Karp, DD ;
ODwyer, PJ ;
Stewart, JA ;
Benson, AB .
MEDICAL ONCOLOGY, 1996, 13 (02) :87-93
[8]   Oesophago-gastric adenocarcinoma - an epidemiological perspective [J].
Forman, D .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 :55-60
[9]  
Futatsuki K, 1994, Gan To Kagaku Ryoho, V21, P1033
[10]   Total gastrectomy is not necessary for proximal gastric cancer [J].
Harrison, LE ;
Karpeh, MS ;
Brennan, MF .
SURGERY, 1998, 123 (02) :127-130